CD25 | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Regulatory Trial results

25 July 2024

Roche’s Skyscraper looks on shaky foundations

Roche curbs its TIGIT push, while a co-stimulation crunch could be bad news for Regeneron.

Subscribe to CD25